Quarterly Period Covered: Second quarter of fiscal year 2026 (October 1 - December 31, 2025), filed February 5, 2026 Company Overview: Cardinal Health Inc is a wholesale drug distributor and pharmaceutical services company incorporated in Ohio with headquarters in Dublin, OH; operates across multiple business segments serving the healthcare industry Financial Statements Included: The filing…

Our analysis rates this filing BEARISH. Cardinal Health faces a HIGH concern level (7.2/10) driven by aggressive acquisition velocity creating material execution risk. The company completed five acquisitions in 11 months, with the most recent (Solaris Health, November 2025) having minimal…

Concern level: HIGH (7.2/10). Key factors: Five acquisitions completed in 11-month period (ION, GIA, ADS, Urology America, Solaris Health) creating compounded integration execution risk - severity escalated to 8/10; Significant goodwill and intangible asset impairment exposure from recent acquisitions with material valuation at risk if synergies fail to materialize - severity 7/10; Strategic…

Notable risk changes: Aggressive acquisition strategy in FY2026 with 5 acquisitions (ION, GIA, ADS, Urology America, Solaris Health) creating significant integration execution risk and goodwill impairment exposure - represents material strategic shift; Entry into specialty healthcare services (GIA, Solaris Health, Urology America) exposes Cardinal to different regulatory, reimbursement, and operational risks than…

The model predicts CAH will underperform the S&P 500 by about 0.0% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.